Ashwin is a Principal in EY-Parthenon’s Life Sciences practice. He works with biopharmaceutical companies to support corporate growth and commercial brand strategy, as well as companies providing commercial services to biopharma. Ashwin supports his clients in organic growth strategy, business development strategy, portfolio strategy and asset-level commercial strategy across therapeutic areas, especially in oncology, immunology and cardiometabolic health.
He has also led numerous commercial due diligences (buy-side and sell-side) in commercial biopharma services across marketing, sales, medical affairs, market access, data/analytics and patient services. Ashwin holds a BS in Microbiology from the University of California, Berkeley and an MBA from Columbia Business School.
How Ashwin is building a better working world
Ashwin is building a better working world by supporting the life sciences industry in increasing companies’ effectiveness and efficiency in their strategy and operations, from the corporate, functional, business unit and product perspectives. His goal is to advise these companies such that they are better able to bring life-changing medicines and interventions to patients who need them.